1.北京中医药大学研究生院,北京 100029
2.中国中医科学研究院西苑医院肾病科,北京 100091
王湘鹏,男,25岁,硕士研究生。研究方向:中医药治疗肾脏疾病。
余仁欢,E-mail:tezhongyu@vip.sina.com
纸质出版日期:2024-04-25,
收稿日期:2023-06-30,
扫 描 看 全 文
王湘鹏,曾勤,杨嘉仪,等.余仁欢基于肠道菌群学说从脾论治特发性膜性肾病经验[J].北京中医药,2024,43(4):381-384.
WANG Xiangpeng,ZENG Qin,YANG Jiayi,et al.Yu Renhuan's experience in the treatment of idiopathic membranous nephropathy from the spleen based on intestinal flora[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):381-384.
王湘鹏,曾勤,杨嘉仪,等.余仁欢基于肠道菌群学说从脾论治特发性膜性肾病经验[J].北京中医药,2024,43(4):381-384. DOI: 10.16025/j.1674-1307.2024.04.010.
WANG Xiangpeng,ZENG Qin,YANG Jiayi,et al.Yu Renhuan's experience in the treatment of idiopathic membranous nephropathy from the spleen based on intestinal flora[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):381-384. DOI: 10.16025/j.1674-1307.2024.04.010.
越来越多的证据表明肠道菌群紊乱可能参与特发性膜性肾病的发生发展。中医学中“脾”的功能可能是通过肠道菌群及其代谢产物所体现。余仁欢教授拟定具有健脾益气、祛湿和络功效的健脾祛湿和络方,通过调节肠道菌群来改善特发性膜性肾病的预后,为临床防治特发性膜性肾病提供新思路和新治法。
特发性膜性肾病脾肾互赞肠道菌群健脾祛湿活络余仁欢
RUAN XL, JIANG YY, GUO X, et al. Progress in the molecular mechanism of membrane nephropathy[J]. JCMP, 2022,4(3):153-155.
BRENNER BM. The kidney [M].9th ed.Philadelphia: Saunders, 2012:1100-1380.
WOO KT,CHAN CM,LIM C,et al. A global evolutionary trend of the frequency of primary glomerulonephritis over the past four decades[J]. Kidney Dis, 2019,5(4):247-258.
ZHAO YY. Recent advances of gut microbiota in chronic kidney disease patients[J]. Explor Med, 2022,3(3):260-274.
温永天, 王凤云, 唐旭东,等. 从肠道菌群探讨“内伤脾胃,百病由生”的科学内涵[J]. 中华中医药杂志,2022,37(8):4334-4337.
吴成态, 张铭, 张静,等. 健脾益肾法治疗特发性膜性肾病的Meta分析[J]. 中华中医药学刊,2020,38(7):163-168.
MEIJERS BK, EVENEPOEL P. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression[J]. Nephrol Dial Transplant, 2011,26(3):759-761.
LI M, WEI L, SUN J, et al. Association of gut microbiota with idiopathic membranous nephropathy[J]. BMC Nephrol, 2022,23(1):164.
LANG R, WANG XH, LI AF, et al. Effects of Jian Pi Qu Shi Formula on intestinal bacterial flora in patients with idiopathic membranous nephropathy: A prospective randomized controlled trial[J]. Chronic Dis Transl Med, 2020,6(2):124-133.
SHANG J, ZHANG Y, GUO R, et al. Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy[J]. Adv Sci (Weinh), 2022,9(28):e2201581.
WIECH T, REINHARD L, WULF S, et al. Bacterial infection possibly causing autoimmunity: Tropheryma whipplei and membranous nephropathy[J]. Lancet, 2022,400(10366):1882-1883.
MOTAVALLI R, ETEMADI J, SOLTANI-ZANGBAR MS, et al. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy[J]. Cytokine, 2021,141:155452.
ZHANG Y, ZHAO J, QIN Y, et al. Specific alterations of gut microbiota in patients with membranous nephropathy: A systematic review and meta-analysis[J]. Front Physiol, 2022,13:909491.
ARPAIA N, CAMPBELL C, FAN X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation[J]. Nature, 2013,504(7480):451-455.
GENG XQ, MA A, HE JZ, et al. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways[J]. Acta Pharmacol Sin, 2020,41(5):670-677.
DONG L, WEI W, HAN M, et al. Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study[J]. Lipids Health Dis, 2021,20(1):122.
DONG L, LI YQ, GUO SM, et al. Hypercholesterolemia correlates with glomerular phospholipase A2 receptor deposit and serum anti-phospholipase A2 receptor antibody and predicts proteinuria outcome in idiopathic membranous nephropathy[J]. Front Immunol, 2022,13:905930.
COMPANYS J, GOSALBES MJ, PLA-PAGÀ L, et al. Gut microbiota profile and its association with clinical variables and dietary intake in overweight/obese and lean subjects: A cross-sectional study[J]. Nutrients, 2021,13(6):2032.
刘玉旋,李平,梁昌昌,等.276例特发性膜性肾病中医证候分布及其影响因素分析[J].世界中医药,2022,17(22):3229-3234,3241.
郎睿.健脾祛湿和络方治疗特发性膜性肾病的队列研究及基于肠道菌群的机制探索[D].北京:中国中医科学院,2019.
郎睿, 王新慧, 张涛,等. 健脾祛湿和络方治疗特发性膜性肾病的队列研究[J]. 空军医学杂志,2021,37(6):510-514.
张荣融.健脾祛湿和络方治疗特发性膜性肾病的临床观察[D].北京:中国中医科学院,2019.
曾勤.基于CD4+T淋巴细胞探究健脾祛湿和络方治疗特发性膜性肾病的作用机制[D].北京:北京中医药大学,2021.
TAN RZ, DIAO H, LI JC, et al. Astragalus mongholicus bunge and panax notoginseng formula (A&P) combined with bifidobacterium contribute a renoprotective effect in chronic kidney disease through inhibiting macrophage inflammatory response in kidney and intestine[J]. Front Physiol, 2020,11:583668.
STAPPENBECK TS, HOOPER LV, GORDON JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via paneth cells[J]. Proc Natl Acad Sci USA, 2002,99(24):15451-15455.
SEARS CL. A dynamic partnership: celebrating our gut flora[J]. Anaerobe, 2005,11(5):247-251.
LATHROP SK, BLOOM SM, RAO SM, et al. Peripheral education of the immune system by colonic commensal microbiota[J]. Nature, 2011,478(7368):250-254.
LIU R, PENG C, JING D, et al. Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria[J]. Exp Dermatol, 2022,31(2):242-247.
LWANG XH, YANG YN, LIANG Y, et al. Structural modulation of gut microbiota during alleviation of experimental passive Heymann nephritis in rats by a traditional Chinese herbal formula[J]. Biomed Pharmacother, 2022,145:112475.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构